Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Revolution Medicines Inc shares valued at $496,800 were purchased by MARK A GOLDSMITH on Oct 17 ’25. At $49.68 per share, MARK A GOLDSMITH acquired 10,000 shares.
Also, JEFFREY TODD CISLINI purchased 12,000 shares, netting a total of over 596,160 in proceeds.
Before that, MARK A GOLDSMITH had added 10,000 shares to its account. In a trade valued at $495,600, the Director bought Revolution Medicines Inc shares for $49.56 each.
As published in their initiating research note from RBC Capital Mkts on November 03, 2025, Revolution Medicines Inc [RVMD] has been an Outperform and the price target has been revised to $77. Analysts at Mizuho started covering the stock with ‘”an Outperform”‘ outlook in a report released in late October.
Analyzing RVMD Stock Performance
On last trading session, Revolution Medicines Inc [NASDAQ: RVMD] rose 3.44% to $61.38. The stock’s lowest price that day was $59.4, but it reached a high of $63.15 in the same session. During the last five days, there has been a surge of approximately 4.26%. Over the course of the year, Revolution Medicines Inc shares have jumped approximately 9.86%. Shares of the company reached a 52-week high of $63.15 on 11/06/25 and a 52-week low of $29.17 on 04/07/25.
Support And Resistance Levels for Revolution Medicines Inc (RVMD)
According to the 24-hour chart, there is a support level at 59.47, which, if violated, would cause prices to drop to 57.56. In the upper region, resistance lies at 63.22. The next price resistance is at 65.06. RSI (Relative Strength Index) is 81.19 on the 14-day chart, showing overbought technical sentiment.
Is Revolution Medicines Inc subject to short interest?
Stocks of Revolution Medicines Inc saw a sharp rise in short interest on 2025-10-15 jumping by 1.31 million shares to 19.36 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 18.05 million shares. A jump of 6.77% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.29 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.29.
Which companies own the most shares of Revolution Medicines Inc (RVMD)?
In terms of Revolution Medicines Inc share price expectations, FactSet research, analysts set an average price target of 77 in the next 12 months, up nearly 29.76% from the previous closing price of $59.34. Analysts anticipate Revolution Medicines Inc stock to reach 99 by 2025, with the lowest price target being 72. In spite of this, 13 analysts ranked Revolution Medicines Inc stock as Buy at the end of 2025. On September 05, 2025, Truist assigned a price target of “a Buy” to the stock and initiated coverage with a $99.
